Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Mitogen-Activated Protein Kinase Kinase Inhibitor"'
Autor:
Chihiro Murata, Yusuke Murakami, Takuma Fukui, Sakurako Shimokawa, Koh-Hei Sonoda, Kimihiko Fujisawa
Publikováno v:
Case Reports in Ophthalmology, Vol 13, Iss 2, Pp 542-549 (2022)
The aim of this paper was to report the cases of 3 consecutive patients with mitogen-activated protein kinase kinase inhibitor (MEKi)-associated retinopathy with characteristic multiple serous retinal detachments (SRDs). A functional analysis of the
Externí odkaz:
https://doaj.org/article/c18da8d9af9a42a7859cf58d240c0f23
Autor:
Mie Mochizuki, Satoshi Fukushima, Ayato Hayashi, Takashi Inozume, Hiroshi Koga, Zentaro Yamagata, Makoto Wada, Taku Fujimura, Jun Asai, Hiroshi Igaki, Hiroshi Yokomichi, Yasuhiro Nakamura, Kenjiro Namikawa
Publikováno v:
JMA Journal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4e22d412dd2ae6a69656892d5d1a89
https://doi.org/10.31662/jmaj.2020-0016
https://doi.org/10.31662/jmaj.2020-0016
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alan P. Brown
Publikováno v:
Biomarkers in Drug Discovery and Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fa12ed66afa6cd5c8a3c9c4c6c61f34
https://doi.org/10.1002/9781119187547.ch13
https://doi.org/10.1002/9781119187547.ch13
Autor:
Haixia Cao, Changwen Jing, Jifeng Feng, Huizi Li, Jianzhong Wu, Siwen Liu, Zhuo Wang, Rong Ma, Yuanyuan Du
Publikováno v:
Molecular Medicine Reports
Mitogen‑activated protein kinase kinase (MEK) small molecule inhibitors have been investigated in preclinical or clinical trials for the treatment of cancer. In the present study the genetic test results of 120 patients with colorectal cancer (CRC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3b2429d4c0e8e8d0645d439f943f35
http://europepmc.org/articles/PMC6323316
http://europepmc.org/articles/PMC6323316
MEK inhibition prevents TGF-β1-induced myofibroblast transdifferentiation in human tenon fibroblasts
Publikováno v:
Molecular Medicine Reports
Subconjunctival fibrosis represents the primary cause of postoperative failure of trabeculectomy, and at present there is a lack of effective intervention strategies. The present study aimed to investigate the effect of the mitogen‑activated protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7532a3b550f31cb94ea41361f192116e
http://europepmc.org/articles/PMC6297771
http://europepmc.org/articles/PMC6297771
Publikováno v:
Journal of the American Academy of Dermatology. 82:998-1000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc6f0738693450be8e9c61a1aa54286
https://doi.org/10.1016/j.jaad.2019.10.003
https://doi.org/10.1016/j.jaad.2019.10.003
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kunitoshi Konda, Noritoshi Kawate, Nobutada Sakagami, Shinji Hashimura, Hiromichi Tamada, Toshio Inaba
Publikováno v:
The Journal of Veterinary Medical Science
This study investigated whether treatment with the mitogen-activated protein kinase kinase inhibitor U0126 during in vitro maturation (IVM), which has previously been reported to improve oocyte developmental competence, is practical for use in calf p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f8069025101bd4f0307383d172fdd8
https://doi.org/10.1292/jvms.18-0460
https://doi.org/10.1292/jvms.18-0460
Autor:
Martine J. Jager, Elon H.C. van Dijk, Gregorius P M Luyten, Camiel J. F. Boon, Johannes R. Vingerling, Wim H. J. Kruit
Publikováno v:
Acta ophthalmologica, 96(7), 712-718. Copenhagen Scriptor
Acta Ophthalmologica, 96(7), 712-718
Acta Ophthalmologica, 96(7), 712-718. Wiley-Blackwell Publishing Ltd
Acta Ophthalmologica, 96(7), 712-718
Acta Ophthalmologica, 96(7), 712-718. Wiley-Blackwell Publishing Ltd
Purpose To analyse ophthalmological adverse events associated with mitogen-activated protein kinase kinase (MEK) inhibition with pimasertib treatment for metastatic cutaneous melanoma (CM). Methods In this prospective observational, cohort-based, cro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0ec930ad9e0d8d6dacfd29d071ab25
https://doi.org/10.1111/aos.13677
https://doi.org/10.1111/aos.13677